Minneapolis Hepatitis C Resource Center, Minneapolis VA Medical Center, University of Minnesota School of Medicine, Minnesota, USA.
Psychosomatics. 2010 Mar-Apr;51(2):149-56. doi: 10.1176/appi.psy.51.2.149.
Although the hepatitis C virus (HCV) alone increases the risk of cirrhosis, alcohol use is thought to act synergistically with HCV to significantly hasten the development of fibrosis.
The authors assessed the impact of brief medical counseling or integrated-care approaches to lessen or eliminate alcohol use in these vulnerable patients.
This retrospective study describes the effect of brief alcohol treatment delivered in a hepatitis clinic on drinking outcomes and antiviral treatment eligibility: 47 heavy-drinking chronic hepatitis C patients received a brief intervention performed by medical clinicians, with follow-up by a psychiatric nurse-specialist.
At the last follow-up, 62% of patients reported >50% drinking reduction; these included 36% who achieved abstinence. Only 6% of patients were excluded from antiviral therapy.
Brief treatment addressing heavy drinking delivered by hepatitis clinicians with psychiatric-specialist follow-up was associated with abstinence or a significant reduction in alcohol consumption in over 50% of patients.
虽然丙型肝炎病毒 (HCV) 单独就会增加肝硬化的风险，但人们认为酒精的使用与 HCV 具有协同作用，可显著加速纤维化的发展。
作者评估了简短的医学咨询或综合护理方法对减轻或消除这些易感染患者饮酒的影响。
本回顾性研究描述了在肝炎诊所中提供的简短酒精治疗对饮酒结果和抗病毒治疗资格的影响：47 名重度饮酒的慢性丙型肝炎患者接受了由临床医生进行的简短干预，并由精神科护士专家进行随访。
在上一次随访中，62%的患者报告饮酒量减少了>50%；其中包括 36%的患者达到了戒酒。只有 6%的患者被排除在抗病毒治疗之外。
由肝炎临床医生提供并由精神科专家进行后续治疗的简短治疗方法，针对重度饮酒问题，可使超过 50%的患者达到戒酒或显著减少饮酒量。
